With the advance in high-throughput sequencing technology, it is feasible to investigate the role of common and rare variants in disease risk prediction. While the new technology holds great promise ...
The report focused primarily on phase 3 confirmatory clinical trials for assessing the safety and efficacy of drugs, biologic products, and some medical devices, for which the bar of scientific rigor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results